Scholarlink

Purpose <p>Sarcomas are among the leading causes of cancer death in children, adolescents, and young adults and survival has not been substantially improved for decades. Reducing the diagnostic interval could contribute meaningfully to increased survival at a low- cost. This study provided much-needed knowledge of the prediagnostic patient trajectories to direct future clinical efforts.</p> Methods <p>This population-based study examined the use of healthcare services in the two years preceding diagnosis in 1524 children, adolescents, and young adults with sarcoma compared to the background population, based on Danish national register data from 1997 to 2020.</p> Results <p>Sarcoma patients were more likely than the background population to have contacts in the primary healthcare sector, hospital outpatient clinics, and emergency rooms, and to fill prescriptions for pain- and antimicrobial medication for up to 24 consecutive months before diagnosis.</p> <p>Patients with metastatic sarcoma at the time of diagnosis were more likely than non-metastatic patients to use healthcare services in the last 2–4&#xa0;months prior to diagnosis.</p> Conclusion <p>Reducing the diagnostic interval in early-life sarcomas should be explored as a low-cost complement to new, advanced treatments to improve survival. Efforts should focus on improving the selection of CAYA with musculoskeletal symptoms for early referral and a better understanding of the diagnostic pathway within the secondary healthcare system.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Use of healthcare services and prescription medication prior to sarcoma diagnosis in children, adolescents, and young adults in 1997–2020: a population-based cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年10月9日

查看全文
  • Daniel Thor Halberg Dybdal,
  • Ólafur Birgir Davidsson,
  • Signe Holst Søegaard,
  • Michael Mørk Petersen,
  • Ninna Aggerholm-Pedersen,
  • Henrik Hjalgrim,
  • Klaus Rostgaard,
  • Lisa Lyngsie Hjalgrim

摘要

Purpose

Sarcomas are among the leading causes of cancer death in children, adolescents, and young adults and survival has not been substantially improved for decades. Reducing the diagnostic interval could contribute meaningfully to increased survival at a low- cost. This study provided much-needed knowledge of the prediagnostic patient trajectories to direct future clinical efforts.

Methods

This population-based study examined the use of healthcare services in the two years preceding diagnosis in 1524 children, adolescents, and young adults with sarcoma compared to the background population, based on Danish national register data from 1997 to 2020.

Results

Sarcoma patients were more likely than the background population to have contacts in the primary healthcare sector, hospital outpatient clinics, and emergency rooms, and to fill prescriptions for pain- and antimicrobial medication for up to 24 consecutive months before diagnosis.

Patients with metastatic sarcoma at the time of diagnosis were more likely than non-metastatic patients to use healthcare services in the last 2–4 months prior to diagnosis.

Conclusion

Reducing the diagnostic interval in early-life sarcomas should be explored as a low-cost complement to new, advanced treatments to improve survival. Efforts should focus on improving the selection of CAYA with musculoskeletal symptoms for early referral and a better understanding of the diagnostic pathway within the secondary healthcare system.